Tax payers have paid for development of Pfizers and other pharm companies vaccines plus guarenteed purchase of the product even if it doesn’t work, so why can’t they be required to share successful production method of approved vaccines with other companies? Quantity, it seems is the bottleneck, not distribution and administration.
Just to correct a minor point - Pfizer declined up-front money for R&D, although there was an early contract in place for the U.S. government to buy the vaccine if it worked.
But to your main point - what makes you think that all resources that are capable of producing the vaccines are not being utilized to do so? Pfizer has a huge network of hundreds of companies to which it outsources various aspects production of its many drugs; Moderna is a biotech firm with nothing like Pfizer’s in-house manufacturing infrastructure, so pretty much everything is outsourced.
Pfizer to outsource some drug production, focus on coronavirus vaccine | Reuters
https://cen.acs.org/business/outsourcing/Pfizer-Moderna-ready-vaccine-manufacturing/98/i46
I worked on a project for Bayer Diagnostics back in the mid-90s when HIV was raging, the line looked very similar to what I see when I look at the Pfizer facility videos. The industry has few secrets as far as production facilities go, people jump back and forth working for company to company, so much of the knowledge is assimilated by people bringing knowledge with them.
CSL, the big Australian vaccine producer, has declined to get involved with the Pfizer vaccine manufacture. The production tech is totally different to traditional vaccines. By the time they built a production process and got it working, the initial shortage would be over.
They’re out of luck because the vaccine they were planning to produce got withdrawn, but there are still other “traditional” vaccines on the way that they plan to be involved with.